Sequential coronary artery bypass grafting as the progress of coronary surgery. History of the issue

 M.F. Rotari

References 

1. Akchurin RS, Shiryaev AA. Topical problems of coronary surgery. Мoskva: Geotar-Меd, 2004. 108 р. (in Russ.).
2. Bokeria LA, Rabotnikov VS, Gliantsev SP, Alshibaya MD. Essays on the history of coronary surgery. Мoskva, 2002:149-155. (in Russ.).
3. Sandrikov VA, Yakovlev VF, Shabalkin BV. Intraoperative dynamics of regional myocardial function during aortocoronary shunting. The Russian Journal of Thoracic and Cardiovascular Surgery . 1990:38-41. (in Russ.).
4. Seidalin AO, Zhakaev MA. Composite and sequential shunting in the surgical treatment of patients with diffuse coronary arteriosclerosis. Vestnik khirurgii Kazakhstana. 2009;1:35-39. (in Russ.).
5. Tikhonov KB. Functional heart radiograph. Мoskva, 1978. (in Russ.).
6. Akinci E. et al. Sequential radial artery grafting three-vessel coronary artery disease. Asian Cardiovasc Thorac Ann. 2005;13:161-166.
7. Aleksic M. et al. Pulsatility index determination by flowmeter measurement: a new indicator for vascular resistance. Eur Surg Res. 2004;36:345-349.
8. Bartley TD, Bigelow JC, Page US. Aortocoronary bypass grafting with multiple sequentialanastomosis to a single vein. Arch Surg. 1972;105:915-917.
9. Berne R, Levy М. Cardiovascular physiology. 2d ed. St. Louis: Mosby, 1972.
10. Bigelow JC. et al. Long-term follow-up of sequential aortocoronary venous grafts. Ann Thorac Surg. 1976;22:507-514.
11. Bonatti J. et al. Robotic totally endoscopic multivessel coronary artery bypass grafting: procedure development, challenges, results. Innovations (Phila). 2012;7:3-8.
12. Braunwald E. et al. The hemodynamic of the left side of the heart as studied Ьу simultaneous left arterial, left ventricular and aortic pressures, particular reference to mitral stenosis. Circulation. 1955;12, N 1. Р. 69-81.
13. Cheanvechai C. et al. Bridge saphenous vein graft. J Thorac Cardiovasc Surg. 1975;70:63-68.
14. Dignan RJ, Yeh T, Dyke CM. Reactivity of gastroepiploic and internal mammary arteries. J Thorac Cardiovasc Surg. 1992;103:116-122.
15. Dion R, Etienne PY, Verhelst R. et al. Bilateral mammary grafting. Clinical, functional and angiographic assessment in 400 consecutive patients. Eur J Cardiothorac Surg. 1993;7:287-293.
16. Dogan S. et al. Computer-enhanced totally endoscopic sequential arterial coronary artery bypass. Ann Thorac Surg. 2001;72:610-611.
17. Flemma RJ, Johnson WD, Lepley DJr. Triple aorto-coronary vein bypass as treatment for coronary insufficiency. Arch Surg. 1971;103:82-83.
18. Fujiwara T. et al. Comparison of blood-flow waveforms in different coronary artery bypass grafts. Circulation. 1988;78:1210-1217.
19. Grondin CM, Limet R. Sequential anastomoses in coronary artery grafting: technical aspects and early and late angiographic results. Ann Thorac Surg. 1977;23:1-8.
20. Gwozdziewicz M. et al. Sequential bypass grafting on the beating heart: blood flow characteristics. Ann Thorac Surg. 2006;82:620-623.
21. Harjola P-T. et al. Sequential internal mammary artery (IMA) grafts in coronary artery bypass surgery. Thorac Cardiovasc Surg. 1984;32:288-292.
22. Hoffinan JI. Determinants and prediction of transmural myocardial perfusion. Cerculation. 1980;62:187-198.
23. Jan T. Christenson, Schmuziger M. Sequential venous bypass grafts: results 10 years later. Ann Thorac Surg. 1997;63:371-376.
24. Kawasuji M. et al. A new vein holder for side-to-side saphenous-coronary anastomosis. Kyobu Geka. 1992;45:225-226.
25. Kieser TM, Fitz Gibbon GM, Keon WJ. Sequential coronary bypass grafts. Long-term follow-up. J Thorac Cardiovasc Surg. 1986;91:767-272.
26. Kim HJ. et al. The impact of sequential versus single anastomoses on flow characteristics and mid-term patency of saphenous vein grafts in coronary bypass grafting. J Thorac Cardiovasc Surg. 2011;141:750-754.
27. Lehr EJ. et al. Axillary-coronary sequential vein graft for total endoscopic triple coronary artery bypass. Ann Thorac Surg. 2010;90:e79-81.
28. Lev-Ran O. et al. Off-pump coronary revascularization of the circumflex system: comparison between sequential and nonsequential arterial grafts. Heart Surg Forum. 2005;8:E201-206.
29. Loop FD. Sequential coronary artery anastomoses. Ann Thorac Surg. 1974;17:637-638.
30. Marasco S, Esmore D. A novel method for performing sequential grafts with the radial artery. Ann Thorac Surg. 2002;74:1262-1263.
31. McBride LR, Barner HB. The left internal mammary artery as a sequential graft to the left anterior descending system. J Thorac Cardiovasc Surg. 1983;86:703-705.
32. Muneretto C. et al. Safety and usefulness of composite grafts for total arterial myocardial revascularization: a prospective randomized evaluation. J Thorac Cardiovasc Surg. 2003;125:826-835.
33. Nakajima H. et al. Determinants for successful sequential radial artery grafting to the left circumflex and right coronary arteries. Interact Cardiovasc Thorac Surg. 2012;12:125-129.
34. Noyez L, de Jager MJ, Markou ALP. Quality of life after cardiac surgery: underresearched research. Interact. Cardiovasc Thorac Surg. 2011;13:511-514.
35. Ofili EO. et al. Differential characterization of blood flow, velocity, and vascular resistance between proximal and distal normal epicardial human coronary arteries: analysis by intracoronary Doppler spectral flow velocity. Am Heart J. 1995;130:37-46.
36. O'Neill MJ. et al. A rationale for the use of sequential coronary artery bypass grafts. J Thorac Cardiovasc Surg. 1981;81:686-690.
37. Ouzounian M. et al. The impact of sequential grafting on clinical outcomes following coronary arterybypass grafting. Eur J Cardiothorac Surg. 2010;38:579-584.
38. Quigley RL. Sequential bypass on the beating heart can be achieved without compromising patient safety or regional myocardial blood flow. Int Surg. 2010;95:257-260.
39. Rittgers SE, Karayannacos PE, Guy JF. et al. Velocity distribution and intimal proliferation in autologous vein grafts in dogs. Circ Res. 1978;42:792-801.
40. Schwann TA. et al. Sequential radial artery grafts for multivessel coronary artery bypass graft surgery: 10-year survival and angiography results. Ann Thorac Surg. 2009;88:31-39.
41. Shimamura Y, Hayashi I. A novel side graft holder for coronary artery bypass grafting. Ann Thorac Surg. 2009;87:1628-1629.
42. Shimamura Y, Hayashi I. Graft fixation with a side graft holder for sequential and composite graft anastomosis in coronary artery bypass surgery. Interact Cardiovasc Thorac Surg. 2009;9:939-942.
43. Tector AJ. et al. The role of the sequential internal mammary artery graft in coronary surgery. Circulation. 1984;70:222-225.
44. Van der Меег J, Reneman RS. The relation of intramyocardial pressure (IМР) to coronary blооd tlow (CBF). Вibl Anat. 1973;11:151-157.
45. Watts KC. et al. Simulation of coronary artery revascularization. J Biomech. 1986;19:491-499.
46. Weinschelbaum EE. et al. Total myocardial revascularization with arterial conduits: radial artery combined with internal thoracic arteries. J Thorac Cardiovasc Surg. 1997;114:911-916. 

  

[PDF] [Contents]  

  

 

Ultrasound diagnosis and monitoring of fetal tachyarrhythmias

 Yu.А. Ivaniv, N.V. Lozynska

References 

1. Donofrio MT, Moon-Grady AJ, Hornberger LK. et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129(21):2183-2242.
2. Gembruch U. Fetal tachyarrythmia. In Fetal Cardiology. Eds. Yagel S, Silverman NH, Gembruch U. 2nd ed. Informa healscare, 2008:461-481.
3. Hornberger LK. Echocardiographic assessment of fetal arrhythmias. Heart. 2007;93:1331-1333.
4. Jaeggi ET, Carvalho JS, De Groot E. et al. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation. 2011;124 (16):1747-1754.
5. Kothari DS, Skinner JR. Neonatal tachycardias: an update. Arch Dis Child Fetal Neonatal. Ed. 2006;91:136-144.
6. Merriman JB, Gonzalez JM, Rychik J, Ural SH. Can digoxin and sotalol therapy for fetal supraventricular tachycardia and hydrops be successful? A case report. J Reprod Med. 2008;53(5):357-359.
7. Respondek-Liberska M. Czestoskurcz plodu. Kardiologia prenatalna dla poloznikow i kardiologow dzieciecych. 2006;12:115-123.
8. Shah A, Moon-Grady A, Bhogal N. et al. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias. Am J Cardiol. 2012;109(11):1614-1648.
9. Strasburger JF, Wakai RT. Fetal cardiac arrhythmia detection and in utero therapy. Nat Rev Cardiol. 2010;7 (5):277-290.
10. Van den Heuvel F, Bink-Boelkens MT, du Marchie Sarvaas, Berger RM. Drug management of fetal tachyarrhythmias: are we ready for a systematic and evidence-based approach? Pacing Clin Electrophysiol. 2008;31:54-57.
11. Wacker-Gussmann A, Strasburger JF, Cuneo BF, Wakai RT. Diagnosis and treatment of fetal arrhysmia. Am J Perinatol. 2014;31(7):617-628.
12. Weber R, Stambach D, Jaeggi E. Diagnosis and management of common fetal arrhythmias. J Saudi Heart Association. 2011;23:61-66.

 

[PDF] [Contents]  

  

 

Clinical characteristics and usage of statins in patients with stable ischemic heart disease referred for angiography or coronary artery bypass grafting

 I.V. Shklianka, O.J. Zharinov, К.O. Mikhaliev, O.A. Epanchintseva

References 

1. Caorsi C, Pineda F, Munoz C. Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardio-pulmonary bypass. Eur Cytokine Netw. 2008;19(2):99-103.
2. De Waal BA, Buise MP, Van Zundert AAJ. Perioperative Statin Therapy in Patients at High Risk for Cardiovascular Morbidity Undergoing Surgery. Br J Anaesth. 2015;114(1):44-52. 
3. ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2016;37:2999-3058.
4. Filion KB, Pilote L, Rahme E. et al. Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery. J Card Surg. 2008;23:209-215. 
5. Hernández-Díaz Y, Tovilla-Zárate CA, Juárez-Rojop I. et al. The role of gene variants of the inflammatory markers CRP and TNF-α in cardiovascular heart disease: systematic review and meta-analysis. Int J Clin Exp Med. 2015;8(8):11958-11984.
6. Kang S, Liu Y, Liu XB. Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials. Clin Ther. 2013;35(8):1125-1136.
7. Кrivoy N, Adler Z, Saloma R. et al. Targeting C-reactive protein levels using high-dose atorvastatin before coronary artery bypass graft surgery. Exp Clin Cardiol. 2008;13(4):171-174.
8. Kuhn EW, Slottosch I, Wahlers T, Liakopoulos OJ. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Systematic Reviews. 2015;8. CD008493.
9. Kulik A, Brookhart MA, Levin R. et al. Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery. Circulation. 2008;118:1785-1792.
10. Kulik A, Ruel M, Jneid H. Secondary prevention after coronary artery bypass graft surgery. A Scientific Statement from the American Heart Association. Circulation. 2015;10:927-964.
11. Kulik A, Voisine P, Mathieu P. et al. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial. Ann Thorac Surg. 2011;92 (4):1284-1290.
12. Liakopoulos OJ, Choi YH, Haldenwang PL. et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30 000 patients. Eur Heart J. 2008;29 (12):1548-1559.
13. Loppnow H, Zhang L, Buerke M et al. Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures. J Cell Mol Med. 2011;15 (4):994-1004.
14. Mills EJ, Wu P, Chong G et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM. 2011;104 (2):109-124.
15. Montalescot G, Sechtem U, Achenbach S. et al. 2013 ESC guidelines on the management of stable coronary artery disease.The task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003.
16. Ozaydin M, Dogan A, Varol E. et al. Statin use before bypass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology. 2007;107:117-121.
17. Pan W, Collard C.D, Coselli J. et al. Effect of Dose and Timing of Preoperative Statins on Mortality After Coronary Artery Bypass Surgery. Ann. Thor. Surgery. 2017 Mar 15. pii: S0003-4975(17)30016-4. doi: 10.1016/j.athoracsur.2016.12.043. [Epub ahead of print]. 
18. Patti G, Chello M, Candura D. et al. Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3. Circulation. 2006;114:145-146.
19. Riley P, Sudarshi D, Johal M. et al. Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study. Int J Clin Pract. 2008;62:374-381. 
20. Stone NJ, Robinson JG, Lichtenstein AH et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2889-2934.
21. Taylor F, Huffman MD, Macedo AF. et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2013. Jan 31 (1). CD004816. doi: 10.1002/14651858.CD004816.pub5.
22. Wahre T, Yundestat A, Smith C et al. Increased Expression of Interleukin-1 in Coronary Artery Disease With Downregulatory Effects of HMG-CoA Reductase Inhibitors. Circulation. 2004;109(16):1966-1972.

 

[PDF] [Contents]  

  

 

Own experience of the surgical treatment of acute myocardial infarction

 A.G. Bitsadze

References 

1. Dolgova I.A, Kuzmich I.N, Shevchenko V.A, Khokhlov A.V, Gritsai A.N, Boyarchuk Ye.M, Chukhleb I.V, Pinchuk A.V, Yepanchintseva O.A. Urgent revascularization and postoperation management of patients with acute myocardial infarction and recurrent ventricular tachycardia / fibrillation. Cardiac Surgery and Interventional Cardiology. 2012;2:45-50. (in Russ.).
2. Alexiou K, Kappert U, Staroske A. et al. Coronary surgery for acute coronary syndrome: which determinants of outcome remain? Clin Research Cardiol. 2008;97:601-608.
3. Assmann A, Boeken U, Akhyari P. et al. Appropriate timing of coronary artery bypass grafting after acute myocardial infarction. Thorac Cardiovasc Surg. 2012;60:446-451.
4. Caceres M, Weiman DS. Optimal timing of coronary artery bypass grafting in acute myocardial infarction. Ann. Thorac. Surg. 2013;95:365-372.
5. Chiu FC, Chang SN, Lin JW. et al. Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: a propensity score analysis. J Thorac Cardiovasc Surg. 2009;138:1326-1330.
6. Dunning J, Versteegh M, Fabbri A. et al. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg. 2008;34:73-92. 
7. Funkat AK, Beckmann A, Lewandowski J. et al. Cardiac surgery in Germany during 2011: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2012;60:371-382.
8. Hagl C, Khaladj N, Peters S. et al. Acute treatment of ST-segment-elevation myocardial infarction: is there a role for the cardiac surgeon? Ann Thorac Surg. 2009;88:1786-1792.
9. Keeley E.C, Boura J.A, Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.
10. Khaladj N, Bobylev D, Peters S. et al. Immediate surgical coronary revascularization in patients presenting with acute myocardial infarction. J Cardiothorac Surg. 2013;8:167-175.
11. Kohl P, Wijns W, Danchin N. et al. Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2010;38 (Suppl.):1-52. 
12. Rastan A.J, Eckenstein J.I, Hentschel B. et al. Emergency coronary artery bypass graft surgery for acute coronary syndrome: beating heart versus conventional cardioplegic cardiac arrest strategies. Circulation. 2006;114:1477-1485. 

[PDF] [Contents]  

  

 

Mitral insufficiencyassessmentby means of transesophageal echocardiography

 V.I. Pavliuk, Т.І. Korotash, L.V. Povaliashko, О.А. Myshakivsky

References 

1. Вach DS, Deeb GM, Bolling SF. Accuracy of intraoperative transesophageal echocardiography for estimating the severity of functional mitral regurgitation. Am J Cardiol. 1995;76(7):508-512.
2. Carpentier A. Cardiac valve surgery - the «French correction». J Thorac Cardiovasc Surg. 1983;86:323-327.
3. Core Topics in Transesophageal Echocardiography. Eds Feneck R, Kneeshaw J, Ranucci M. Cambridge university press, 2010. 416 p.
4. Foster GP, Isselbacher EM, Rose GA. et al. Accurate localization of mitral regurgitant defects using multiplane transesophageal echocardiography. Ann Thorac Surg. 1998;65:1025-1031.
5. Grewal KS, Malkowski MJ, Piracha AR. et al. Effect of general anesthesia on the severity of mitral regurgitation by transesophageal echocardiography. Am J Cardiol. 2000;85(2):199-203.
6. Hahn RT, Abraham T, Adams MS. et al. Guidelines for Per¬forming a Comprehensive Transesophageal Echocardiograph¬ic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anes¬thesiologists. J Am Soc Echocardiogr. 2013;26:921-964.
7. Lambert AS, Miller JP, Merrick SH. et al. Improved evaluation of the location and mechanism of mitral valve regurgitation with a systematic transesophageal echocardiography examination. Anesth Analg. 1999;88:1205-1212.
8. Lee AP, Acker M, Kubo SH. et al. Mechanisms of recurrent functional mitral regurgitation after mitral valve repair in nonischemic dilated cardiomyopathy: Importance of distal anterior leaflet tethering. Circulation. 2009;119:2606-2614.
9. Mathew JP, Swaminathan M, Ayoub CM. Clinical manual and review of transesophageal echocardiography. The McGraw-Hill Companies, 2010. 642 p.
10. Perrino AC Jr, Reeves ST. A Practical Ap¬proach to Transesophageal Echocardiography. Lippincott Williams & Wilkins, 2014. 526 p.
11. Pu M, Griffin BP, Vandervoort PM. et al. The value of assessing pulmonary venous flow velocity for predicting severity of mitral regurgitation: A quantitative assessment integrating left ventricular function. J Am Soc Echocardiogr. 1999;12:736-743.
12. Schiller NB, Foster E, Redberg RF. Transesophageal echocardiography in the evaluation of mitral regurgitation. The twenty four signs of severe mitral regurgitation. Cardiol Clin. 1993;11:399-408.
13. Shanewise JS, Cheung AT, Aronson S. et al. ASE/SCA Guide¬lines for Performing a Comprehensive Intraoperative Multi¬plane Transesophageal Echocardiography Examination: Rec¬ommendations of the American Society of Echocardiography Council for Intraoperative Echocardiography and the Society of Cardiovascular Anesthesiologists Task Force for Certification in Perioperative Transesophageal Echocardiography. J Am Soc Echocardiogr. 1999;12:884-900.
14. Stewart WJ, Currie PJ, Salcedo EE. et al. Evaluation of mitral leaflet motion by echocardiography and jet direction by Doppler color flow mapping to determine the mechanisms of mitral regurgitation. J Am Coll Cardiol. 1992;20:1353-1361.
15. Tribouilloy C, Shen WF, Quere JP. et al. Assessment of severity of mitral regurgitation by measuring regurgitant jet width at its origin with transesophageal Doppler color flow imaging. Circulation. 1992;85:1248-1253.
16. Vegas A. Perioperative Two-Dimensional Transesophageal. Echocardiography. A Practical Handbook. Springer, 2012. 235 p. 

 

[PDF] [Contents]  

  

 

Treating trauma: case studies and early experience with the Zenith Alpha Thoracic Endovascular Graft for treatment of blunt aortic injuries

 B.W. Starnes

References 

  1. Demetriades D, Velmahos GC, Scalea TM, et al. Operative repair or endovascular stent graft in blunt traumatic thoracic aortic injuries: results of an American Association for the Surgery of Trauma Multicenter Study. J Trauma. 2008;64:561-570.

 

 

[PDF] [Contents]  

  

 

Burkitt lymphoma affecting the right heart. A case from practice

 R.M. Vitovsky, V.P. Zakharova, O.А. Lozovyy, V.V. Isaenko, O.A. Pishchurin

References 

1. Knyshov GV, Vitovsky RM, Zakharova VP. Tumors of the heart. Problems of diagnosis and surgical treatment. Kyiv: Press of Ukraine, 2005. 256 с. (in Russ.).
2. Asch FM, Bieganski SP, Panza JA, Weissman NJ. Real-time 3-dimensional echocardiography evaluation of intracardiac masses. Echocardiography. 2006;23(3):218-224.
3. Chan O, Igwe M, Breburda CS, Amar S. Burkitt lymphoma presenting as an intracardiac mass: case report and review of literature. Am J Case Rep. 2016;3(17):553-558.
4. Hoffmeier A, Sindermann JR, Scheld HH, Martens S. Cardiac tumors - diagnosis and surgical treatment. Dtsch Arztebl Int. 2014;111(12):205-211.
5. Gowdamarajan A, Michler RE. Therapy for primary cardiac tumors: is there a role for heart transplantation? Curr Opin Cardiol. 2000;15(2):121-125.
6. Yuan S.M, Shinfeld A, Lavee J. et al. Imaging morphology of cardiac tumors. Cardiol J. 2009;16(1):26-35.
7. Jimenez Mazuecos J.M, Fuentes Manso R, Segovia Cubero J. et al. Is heart transplantation for primary cardiac sarcoma a useful therapeutic option? Rev Esp Cardiol. 2003;56(4):408-411.
8. Longino LA, Meeker IA. Jr. Primary cardiac tumors in infancy. J Pediatr. 1953;43(6):724-731.
9. Majano-Lainez RA. Cardiac tumors: a current clinical and pathological perspective. Crit Rev Oncog. 1997;8(4):293-303.
10. Simpson L, Kumar SK, Okuno SH. et al. Malignant primary cardiac tumors: review of a single institution experience. Cancer. 2008;112(11):2440-2446.
11. Neragi-Miandoab S, Kim J, Vlahakes GJ. Neragi-Miandoab S. Malignant tumors of the heart: a review of tumor type, diagnosis and therapy. Clin Oncol. 2007;19(10):748-756.
12. Zhang PJ, Brooks JS, Goldblum JR. et al. Primary cardiac sarcomas: a clinicopathologic analysis of a series with follow-up information in 17 patients and emphasis on long-term survival. Hum Pathol. 2008;39(9):1385-1395.
13. Reardon MJ, Walkes JC, Benjamin R. Therapy insight: malignant primary cardiac tumors. Nat Clin Pract Cardiovasc Med. 2006;3(10):548-553.
14. Shanmugam G. Primary cardiac sarcoma. Eur J Cardiothorac Surg. 2006;29(6):925-932.
15. Kośmider A, Jaszewski R, Marcinkiewicz A. et al. 23-year experience on diagnosis and surgical treatment of benign and malignant cardiac tumors. Arch Med Sci. 2013;9(5):826-830. 
 

 

[PDF] [Contents]  

  

 

Overview of American Heart Association / American College of Cardiology guidelines 2017 for management of patients with valvular heart disease

 M.Т. Vatutin,  G.A. Smyrnova, G.G. Taradin, Yu.P. Gritsenko, K.S. Gasendich

References 

1. Nishimura RA, Otto CM, Bonow RO. et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159–e1195.

 

[PDF] [Contents]